Viatris’s stock price fell to $10.77. Shareholders have lost 9% of their capital, which is disappointing considering the S&P ...

NORTHAMPTON, MA / ACCESS Newswire / February 17, 2025 / By Adelina Nedelcu As Leo stands in his office, overseeing the ...

Viatris Inc. (VTRS) is a global healthcare company formed through the merger of Mylan and Upjohn (a division of Pfizer) in ...

Viatris has made a play to expand its branded medicines business by licensing two late-stage drugs from Idorsia – for acute myocardial infarction (AMI) and systemic lupus erythematosus (SLE ...

Viatris, formed from Mylan and Pfizer's Established Brands, has faced stock price volatility since its inception in 2020. I rated Viatris a "Buy" last October, based on management's completion of ...

This was the stock's second consecutive day of losses.

Viatris Inc. (VTRS), headquartered in Canonsburg, Pennsylvania, is a leading global healthcare company dedicated to empowering people worldwide to live healthier at every stage of life.

Shares of Viatris Inc. VTRS rose 1.89% to $10.80 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.04% to 6,115.07 and the ...

In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against the other high-yield dividend stocks. Dividend stocks have been investors’ favorites for a long ...

NORTHAMPTON, MA / ACCESS Newswire / February 17, 2025 / By Adelina Nedelcu?As Leo stands in his office, overseeing the entrance of Viatris' bustling office in the Netherlands, he reflects on the 50 ye ...